Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine Plus Metformin in Clomiphene-resistant Obese PCOS Women
NCT03108963Phase 2
Key facts
- Status
- Completed
- Start
- Jan 2017
- Primary completion
- Mar 2018
- Countries
- 1
- Sponsor
- Zagazig University
- Modality
- Small Molecules
- Conditions
- polycystic ovary syndrome (PCOS)
01
Overview
Phase 2, randomised trial in polycystic ovary syndrome (PCOS) comparing L-carnitine and Metformin with Placebo (2 arms). Primary endpoint: Pregnancy rate at 3 months. Started Jan 2017; status: completed.
02
Design
2 arms- Study design
- Randomized
L-carnitine and Metformin
L-carnitine and Metformin in Obese PCOS Women trying induction of ovulation with clomiphene citrate.
Placebo
Placebo given to Obese PCOS Women trying induction of ovulation with clomiphene citrate.
03
Who it enrols
Obese, infertile women with clomiphene-resistant PCOS, with no other medical disorders and no hormonal treatment in the previous 3 months.
04
Endpoints
Primary
Pregnancy rate
Secondary
Ovulation rate
Abortion rate
Insulin resistance parameters
Lipid metabolism parameters
Beyond the preview
Go deeper on NCT03108963.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03108963.